RemeGen Co., Ltd. logo

RemeGen Co., Ltd.

HKEX:9995.HK

Overview | Financials
Company Name RemeGen Co., Ltd.
Symbol 9995.HK
Currency HKD
Price 12.46
Market Cap 12,161,150,576
Dividend Yield 0%
52-week-range 11.26 - 49
Industry Biotechnology
Sector Healthcare
CEO Dr. Jianmin Fang
Website https://www.remegen.com

An error occurred while fetching data.

About RemeGen Co., Ltd.

RemeGen Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an

Related Stocks

Jinxin Fertility Group Limited logo

Jinxin Fertility Group Limited

1951.HK

2.23 HKD

HUTCHMED (China) Limited logo

HUTCHMED (China) Limited

0013.HK

27.9 HKD

3SBio Inc. logo

3SBio Inc.

1530.HK

5.84 HKD

Shanghai Haohai Biological Technology Co., Ltd. logo

Shanghai Haohai Biological Technology Co., Ltd.

6826.HK

40.05 HKD

Jiangsu Recbio Technology Co., Ltd. logo

Jiangsu Recbio Technology Co., Ltd.

2179.HK

8.8 HKD

Sihuan Pharmaceutical Holdings Group Ltd. logo

Sihuan Pharmaceutical Holdings Group Ltd.

0460.HK

0.55 HKD

Grand Pharmaceutical Group Limited logo

Grand Pharmaceutical Group Limited

0512.HK

4.44 HKD

InnoCare Pharma Limited logo

InnoCare Pharma Limited

9969.HK

5.17 HKD

LifeTech Scientific Corporation logo

LifeTech Scientific Corporation

1302.HK

1.39 HKD

SSY Group Limited logo

SSY Group Limited

2005.HK

3.86 HKD

Financials

Numbers are in millions USD

Numbers are in millions USD